ABL Bio Inc - ESG Rating & Company Profile powered by AI
Industry Group:Pharmaceuticals
The SDG score for ABL Bio Inc represents its reporting of the UN SDGs. If you work at ABL Bio Inc and you wish to use your ESG aseessment, please contact us. Check the bottom of the webpage for potential risks for ABL Bio Inc based on sector, geography and size.
ABL Bio Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 0.0; made up of an environmental score of 0.0, social score of 0.0 and governance score of 0.0.
SDG Transparency Score for ABL Bio Inc ⓘ
0.0
Low Impact0 - 3
Medium
4 - 6
High
7 - 10
What drives the score for ABL Bio Inc ⓘ
0.0
Environmental
0.0
Social
0.0
Governance
Peer Group Comparison
| Rank | Company | SDG Transparency Score ⓘ | Performance |
|---|---|---|---|
| 1 | Caladrius Biosciences Inc | 8.0 | High |
| 1 | Can Fite Biopharma Ltd | 8.0 | High |
| ... | ... | ... | |
| 1967 | Hospira Inc | 0.3 | Low |
| 1967 | PRA Health Sciences Inc | 0.3 | Low |
| 1970 | ABL Bio Inc | 0.0 | Low |
| 1970 | CSPC Innovation Pharmaceutical Co Ltd | 0.0 | Low |
| 1970 | CTC Bio Inc | 0.0 | Low |
| 1970 | Zyden Gentec Ltd | 0.0 | Low |
| 1970 | iNtRON Biotechnology Inc | 0.0 | Low |
| ... | ... | ... |
Frequently Asked Questions
Does ABL Bio Inc have an accelerator or VC vehicle to help deliver innovation?
Does ABL Bio Inc disclose current and historical energy intensity?
Does ABL Bio Inc report the average age of the workforce?
Does ABL Bio Inc reference operational or capital allocation in relation to climate change?
Does ABL Bio Inc disclose its ethnicity pay gap?
Does ABL Bio Inc disclose cybersecurity risks?
Does ABL Bio Inc use carbon offsets or credits exclusively for residual emissions (typically less than ~0.5–5% of total emissions)?
Does ABL Bio Inc offer flexible work?
Does ABL Bio Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does ABL Bio Inc disclose the number of employees in R&D functions?
Does ABL Bio Inc plan to change its portfolio composition to lower the emissions intensity of its energy mix (e.g., by shifting from oil to gas, or by adding lower-carbon options like hydrogen, e-fuels, bioenergy, etc.)?
Does ABL Bio Inc conduct supply chain audits?
Does ABL Bio Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does ABL Bio Inc conduct 360 degree staff reviews?
Does ABL Bio Inc disclose the individual responsible for D&I?
Does ABL Bio Inc disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does ABL Bio Inc disclose current and / or historical scope 2 emissions?
Does ABL Bio Inc disclose water use targets?
Does ABL Bio Inc have careers partnerships with academic institutions?
Did ABL Bio Inc have a product recall in the last two years?
Does ABL Bio Inc disclose incidents of discrimination?
Does ABL Bio Inc allow for Work Councils/Collective Agreements to be formed?
Has ABL Bio Inc issued a profit warning in the past 24 months?
Does ABL Bio Inc disclose parental leave metrics?
Does ABL Bio Inc disclose climate scenario or pathway analysis?
Does ABL Bio Inc disclose current and / or historical scope 1 emissions?
Does ABL Bio Inc explicitly state that carbon offsets or credits are separate from its emissions-reduction progress or that they are not counted toward its emissions-reduction targets?
Are Operating Expesnses linked to emissions reduction?
Does ABL Bio Inc disclose the pay ratio of women to men?
Does ABL Bio Inc support suppliers with sustainability related research and development?
Does ABL Bio Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does ABL Bio Inc reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is ABL Bio Inc involved in embryonic stem cell research?
Does ABL Bio Inc disclose GHG and Air Emissions intensity?
Does ABL Bio Inc disclose its waste policy?
Does ABL Bio Inc report according to TCFD requirements?
Does ABL Bio Inc plan to mitigate emissions from future new production assets through measures such as electrifying equipment, carbon capture and storage, repurposing waste gas, methane leak detection and repair, eliminating flaring, etc.?
Does ABL Bio Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does ABL Bio Inc disclose energy use targets?
Does ABL Bio Inc disclose its Renewable Energy targets?
Are emissions metrics verified by STBi?
Does ABL Bio Inc have a policy relating to cyber security?
Potential Risks for ABL Bio Inc
These potential risks are based on the size, segment and geographies of the company.
ABL Bio Inc., a biotech research company, focuses on the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases. Its pipeline drugs include ABL001, cancer immunotherapy, ADC, and ABL301. The company is headquartered in Seongnam, South Korea.